Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Evolus, Inc.

Evolus Rewards™ Patient Loyalty Program Surpasses 1 Million Enrolled Consumers
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in Australia
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus to Participate in Canaccord Genuity’s 43rd Annual Growth Conference
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus Announces Expansion into U.S. Dermal Filler Market with Evolysse™, a First-Generation Cold Technology HA by Symatese
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus to Report First Quarter 2023 Results and Provide Business Update
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus Initiates Nuceiva® Launch in Germany and Austria
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus to Participate in the Virtual 11th Annual SVB Leerink Global Healthcare Conference
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Evolus Enters Into $125 Million Credit Facility with Pharmakon Advisors
From Evolus, Inc.
Via Business Wire
Tickers EOLS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.